Ruxolitinib Cream Has Dual Efficacy on Pruritus and Inflammation in Experimental Dermatitis

Ruxolitinib Cream Has Dual Efficacy on Pruritus and Inflammation in Experimental Dermatitis

The goal of this study was to elucidate the anti-pruritic and anti-inflammatory efficacy of ruxolitinib cream in experimentally-induced dermatitis. Atopic dermatitis (AD), the most common chronic relapsing inflammatory skin disease, significantly impairs patients’ quality of life, with pruritus bein...

Full description

Bibliographic Details
Main Authors: Monika D. Scuron, Brittany L. Fay, Andrew J. Connell, Michael T. Peel, Paul A. Smith
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Immunology
Subjects:
dermatitis
ruxolitinib
inflammation
pruritus
JAK/STAT signaling pathway
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2020.620098/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2020.620098/full

Similar Items